- Gleevec (Imatinib) fends off Leukemia for a decade without any new safety concerns, per New England Journal of Medicine publication http://www.nejm.org/doi/full/10.1056/nejmoa1609324 3 comments science
Linking pages
Linked pages
Related searches:
Search whole site: site:www.nejm.org
Search title: Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia | NEJM
See how to search.